Red Light Holland Corp. announced on May 4, 2026 [1], that it will rebrand as Rhelion Life Sciences Corp. [2].

The move signals a strategic pivot for the Toronto-based company as it moves away from its original branding to prioritize clinical research. This transition aims to align the corporate identity with a more rigorous, pharmaceutical approach to the psychedelic sector.

According to company filings, the rebranding reflects an evolution into a focused, science-driven life-sciences platform [3]. This new direction is dedicated specifically to psychedelic drug discovery, development, and innovation [3]. By adopting the Rhelion Life Sciences name, the company seeks to better represent its commitment to the medical and scientific community.

Red Light Holland is currently traded under several ticker symbols, including CSE: TRIP, FSE: 4YX, and OTCQB: TRUFF [1]. The company has not yet detailed the exact timeline for when the ticker symbols will change to reflect the new name, but the corporate identity shift was formally declared in May [1].

The company operates out of Toronto, Ontario, where it manages its strategic pivot [1]. The transition to Rhelion Life Sciences comes as the broader industry faces increasing pressure to move from anecdotal evidence to peer-reviewed clinical data.

Management said the change is necessary to reflect the current state of the business. The company is positioning itself as a platform for innovation in the psychedelic space, focusing on the development of new drug candidates, and the refinement of existing therapeutic protocols [3].

“Red Light Holland Corp. announced on May 4, 2026, that it will rebrand as Rhelion Life Sciences Corp.”

This rebranding indicates a transition from a consumer-facing or lifestyle-oriented brand to a clinical biotech entity. By emphasizing 'Life Sciences' and 'drug discovery,' the company is attempting to gain legitimacy with institutional investors and regulatory bodies, moving the focus from the cultural aspects of psychedelics to the pharmaceutical potential of these compounds.